EUVIMEDEUVIMED entdecken
Open Access

Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022–2023

Sarah N Cox iD, Pavitra Roychoudhury iD, Collrane Frivold iD, Zack Acker, Tara M Babu iD, Cassandra L Boisvert, Marco Carone, Brenna Ehmen, Janet A Englund iD, Leora R Feldstein iD, Luis Gamboa, Sally Grindstaff und 19 weitere

Clinical Infectious Diseases · 04.02.2026 · 81 (6) · 1159-1169

DOI: 10.1093/cid/ciaf048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 11.03.2025. Verfasst von Sarah N Cox und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Family Characteristics, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Household transmission of respiratory viruses may drive community spread. Few recent studies have examined household respiratory syncytial virus (RSV) transmission in the United States.

Methods

We conducted a prospective community-based cohort study from 1 June 2022 to 31 May 2023. Participants had blood samples collected and completed nasal swabs and surveys at least weekly, irrespective of symptoms. We tested serum for RSV antibody, nasal swabs by quantitative reverse transcription polymerase chain reaction (RT-qPCR), and performed whole genome sequencing. We evaluated secondary RSV transmission and associated risk factors based on a log-linear Poisson regression model.

Results

RSV was detected among 310 (10%) participants within 200 (20%) households. Most (94%) index cases were symptomatic. We identified 37 cases of potential secondary transmission within 14 days of a distinct index case (10%, 95% confidence interval [CI]: 7%, 14%); median age of index and secondary cases were 6 (interquartile range [IQR]: 3–10) and 35 (7–41) years, respectively, with 89% (24/27) of index cases aged 6 months to 12 years. Factors associated with increased risk of RSV transmission included index case viral detection ≥1 week and contact age ≤12 years. Of 120 sequenced specimens, the main lineages represented were A.d.5.2 (n = 37) and A.d.1 (n = 30). Sequenced viruses from households with ≥2 RSV infections were similar when occurring within ≤14 days (mean pairwise difference 4 [range 0–13], n = 17 households), compared to those >14 days (137 [37–236], n = 2).

Conclusions

Most RSV household transmission occurs from infants and young children to adults. Viral genome sequencing demonstrated that multiple household infections within a 14-day period are likely due to within-household transmission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsFamily CharacteristicsRespiratory Syncytial Virus, HumanHumansFemaleMaleUnited StatesChild, PreschoolInfantProspective StudiesAdultChildAdolescentYoung AdultGenome, ViralMiddle AgedWhole Genome SequencingRisk FactorsAntibodies, ViralGenetic Variation

Stichwörter der Autor:innen

community surveillancegenomicshousehold transmissionrespiratory syncytial virussecondary attack rate

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Kaiser Permanente Center for Health Research, Portland, Oregon, USA.

ORCID-Profile: Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, Tara M Babu, Janet A Englund, Leora R Feldstein, Jennifer L Kuntz, Christina M Lockwood, Mark A Schmidt, Lea M Starita, Alexandra Varga, Ana A Weil, Helen Y Chu

Förderung

  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Cox, S. N., Roychoudhury, P., Frivold, C., Acker, Z., Babu, T. M., Boisvert, C. L., Carone, M., Ehmen, B., Englund, J. A., Feldstein, L. R., Gamboa, L., Grindstaff, S., Grioni, H. M., Han, P. D., Hoffman, K. L., Kim, H. G., Kuntz, J. L., Lo, N. K., Lockwood, C. M., …, & Chu, H. Y. (2026). Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022–2023. Clinical Infectious Diseases, 81(6), 1159-1169. https://doi.org/10.1093/cid/ciaf048

Vancouver

Cox SN, Roychoudhury P, Frivold C, Acker Z, Babu TM, Boisvert CL, et al. Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022–2023. Clinical Infectious Diseases. 2026;81(6):1159-1169. doi:10.1093/cid/ciaf048

BibTeX
@article{Cox2026,
  author = {Cox, Sarah N and Roychoudhury, Pavitra and Frivold, Collrane and Acker, Zack and Babu, Tara M and Boisvert, Cassandra L and Carone, Marco and Ehmen, Brenna and Englund, Janet A and Feldstein, Leora R and Gamboa, Luis and Grindstaff, Sally and Grioni, Hanna M and Han, Peter D and Hoffman, Katherine L and Kim, Hyeong Geon and Kuntz, Jennifer L and Lo, Natalie K and Lockwood, Christina M and McCaffrey, Kathryn and Mularski, Richard A and Hatchie, Tara L and Reich, Sacha L and Schmidt, Mark A and Smith, Ning and Starita, Lea M and Varga, Alexandra and Yetz, Neil and Naleway, Allison L and Weil, Ana A and Chu, Helen Y},
  title = {Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022–2023},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {81},
  number = {6},
  pages = {1159--1169},
  doi = {10.1093/cid/ciaf048}
}
Kostenlos starten →